ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Language understanding and preferences when reporting symptoms for pediatric patients receiving cancer treatments and their guardians.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe Symptom Screening in Pediatrics Tool (SSPedi) was developed to facilitate symptom assessment among pediatric patients receiving cancer treatments; limited translations are available. The objective was to describe, among non-English pediatric patients receiving cancer treatments and non-English guardians, the language in which they understood symptoms and their language preferences for SSPedi completion.
methodsIn this single-center study, we included patients receiving cancer treatments aged 8-18 years or guardians of patients 2-18 years with non-English first languages. A single interview was conducted where participants were asked whether they understood the words for each of the 15 SSPedi symptoms in their first language, English, or both. We also asked about the importance of SSPedi translation in their first language.
resultsWe included 50 pediatric patients and 155 guardians speaking 49 unique first languages. The number who knew a symptom only in their first language ranged from 2/50 (4.0%) to 6/50 (12.0%) for pediatric patients and ranged from 5/155 (3.2%) to 16/155 (10.3%) for guardians. In general, it was more common for pediatric patients to know a symptom only in English compared to guardians. The number who stated translation into their first language was very or extremely important was 16/50 (32.0%) for pediatric patients and 50/155 (32.2%) for guardians.
conclusionWhile most non-English patients and guardians understood SSPedi symptoms in English, some will require translation in their first language. Given the large number of languages, meeting the needs of those who require translation will require novel approaches.
Indexed as
Identifiers
40016500What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.